EXSEL Drug Patent Profile
✉ Email this page to a colleague
When do Exsel patents expire, and when can generic versions of Exsel launch?
Exsel is a drug marketed by Allergan Herbert and is included in one NDA.
The generic ingredient in EXSEL is selenium sulfide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the selenium sulfide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Exsel
A generic version of EXSEL was approved as selenium sulfide by PADAGIS US on January 10th, 1991.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EXSEL?
- What are the global sales for EXSEL?
- What is Average Wholesale Price for EXSEL?
Summary for EXSEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| DailyMed Link: | EXSEL at DailyMed |
US Patents and Regulatory Information for EXSEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan Herbert | EXSEL | selenium sulfide | LOTION/SHAMPOO;TOPICAL | 083892-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
